ArticleRSC advances2018
Introducing copper and collagen (
Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 8 citations in OpenAlex.
- Polyphosphate in Bone Tissue Engineering: From Molecular Mechanisms to Material Design.Journal of functional biomaterials · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional calcium polyphosphate (CPP) scaffolds have attracted wide attention for repairing bone defects owing to their low cytotoxicity and controllable degradation. However, because of poor mechanical strength, significant brittleness and suboptimal osteoinductivity and osteoconductivity, their further clinical applications are restricted. To overcome these limitations, collagen (Col) coated Cu(ii) ion-doped calcium polyphosphate (CCPP) scaffolds were employed and dopamine (DOPA) was used as a linkage (CCPP/D/Col) to ensure their stable and tight structure. Controllable Cu(ii) ion continuously released from scaffolds together with collagen coating could simultaneously enhance the cytocompatibility, compressive strength and ductility, bone-related gene expression and new bone regeneration. In comparison with the initial CPP specimens, these multifunctional CCPP/D/Col composite scaffolds' crystal grains of CCPP were arranged regularly and well-ordered, and the size and rugosity were more suitable for cell spreading and attachment. Murine bone marrow stem cells (BMSCs) seeded on CCPP/D/Col scaffolds possessed better proliferation and migration, rapid attachment and enhanced expression of osteogenic-related genes, which indicated better bone regeneration. The potential mechanism of this process was further elucidated. Both copper doping and collagen coating could effectively stabilize hypoxia-inducible factor-1α (HIF-1α) that thus stimulates the expression of vascular endothelial growth factor (VEGF). In addition, they could also promote the osteogenic differentiation of cells through stimulating bone-related gene expression. The concept of introducing active ions and biological macromolecules to modify inert ceramics may offer a new strategy to construct a multifunctional composite scaffold for bone tissue regeneration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.